Work

The Effect of the 340b Drug Pricing Program on Access, Out-of-pocket Costs, and Adherence of Oral Targeted Agents in Medicare Beneficiaries With Advanced Prostate Cancer

Year: 2024

Type: article

Study design: Observational Study

Source: Urologic Oncology Seminars and Original Investigations

DOI: 10.1016/j.urolonc.2024.01.060

Authors: Kassem Faraj, Samuel R Kaufman, Lindsey A Herrel, Avinash Maganty, Mary Oerline, Megan E.V. Caram, Vahakn B Shahinian, Brent K Hollenbeck

Institutions: University of Michigan, Massachusetts General Hospital

Language: English

Topic: Economic and Financial Impacts of Cancer

Subfield: Economics and Econometrics

Field: Economics, Econometrics and Finance

Domain: Social Sciences

SDGs: Good health and well-being, Reduced inequalities

Open Access status: closed

OpenAlex ID: W4392807929

FWCI:

Cites:

Cited by:

Related to: 10